Abstract
A recent contribution by Perico et al., recommended the use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in the early stage of SARS-CoV2 infection, preventing the onset of a severe form of COVID-19 and hence reducing the hospitalization rate and the risk of mortality 1. Many previous reports from the same group 2-3 and from ours 4, showed that the use of paracetamol, as recommended by the Italian Ministry of Health since Nov 30 th 2020, usually associated with the advice to monitor one's own developing symptoms at home ("watchful waiting"), increased the risk to be hospitalized.
This article is protected by copyright. All rights reserved.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου